comparemela.com

Latest Breaking News On - Chinese academy of science institute microbiology - Page 3 : comparemela.com

China Approves Coronavirus Vaccine Candidate Without Publishing Data

16 Mar 2021 Chinese health regulators approved a new coronavirus vaccine candidate for emergency use in China on Monday without releasing clinical trial data on its efficacy rate or safety. The head of the Chinese Center for Disease Control, Gao Fu, “led the development of a protein subunit vaccine that was approved by regulators last week for emergency use,” the Chinese Academy of Sciences’ Institute of Microbiology said in a statement” on March 15, according to the Associated Press (AP). China’s Anhui Zhifei Longcom Biopharmaceutical company worked with the Chinese Academy of Sciences to develop the new Chinese coronavirus vaccine candidate. “The team finished phase 1 and phase 2 clinical trials in October and is currently conducting the last phase of trials in Uzbekistan, Pakistan, and Indonesia,” according to Monday’s press release. Uzbekistan launched Phase III clinical trials of the vaccine candidate in December and approved it for emergency use in the co

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.